Radiotherapy and local control in rectal cancer

Area of Science:

• Oncology
• Radiation Oncology
• Surgical Oncology

Background:

• Rectal cancer recurrence is a critical factor influencing patient outcomes.
• Radiotherapy, both pre- and post-operative, is employed to mitigate recurrence rates and enhance local control.
• Optimizing treatment strategies remains crucial for improving survival in rectal cancer patients.

Purpose of the Study:

• To evaluate the efficacy of different radiotherapy regimens in managing rectal cancer.
• To compare the rates of local control and survival based on the timing and type of radiation therapy administered.
• To assess the impact of local recurrence on metastasis incidence and overall survival.

Main Methods:

• Retrospective analysis of 380 rectal cancer patients (T2-T3 stages) treated between 1980-1997.
• Patients received various radiation protocols: postoperative radiotherapy,
• sandwich
• radiotherapy, preoperative concomitant radiochemotherapy, and preoperative radiotherapy with intraoperative radiotherapy (IORT).
• Follow-up data analyzed for local control, metastasis, and survival rates.

Main Results:

• Overall local control rates were 85% at 3 years, 83% at 5 years, and 81% at 10 years.
• Five-year local control rates varied: 76% (postoperative), 83% (
• sandwich
• ), 84% (preoperative chemoradiotherapy), and 93% (preoperative radiotherapy + IORT).
• Preoperative treatments demonstrated significantly better local control than postoperative treatment (p=0.02).
• Local recurrence was associated with higher metastasis rates (35% vs. 16%) and significantly lower 5-year survival (32% vs. 87%).

Conclusions:

• Preoperative radiotherapy, particularly when combined with IORT, offers superior local control for rectal cancer compared to postoperative approaches.
• Achieving local control is strongly correlated with reduced metastasis and improved patient survival.
• These findings underscore the importance of neoadjuvant radiotherapy in rectal cancer management.